Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Shuyou Peng"'
Autor:
Jiasheng Cao, Jiafei Yan, Jiahao Hu, Bin Zhang, Win Topatana, Shijie Li, Tianen Chen, Sarun Jeungpanich, Ziyi Lu, Shuyou Peng, Xiujun Cai, Mingyu Chen
Publikováno v:
Cancer Medicine, Vol 12, Iss 16, Pp 16744-16755 (2023)
Abstract Background The influencing factors, especially time to treatment (TTT), for T1b/T2 gallbladder cancer (GBC) patients remain unknown. We aimed to identify the influencing factors on survival and surgical approaches selection for T1b/T2 GBC. M
Externí odkaz:
https://doaj.org/article/d93fa988ba614e7e88f6c909e3b68e33
Autor:
Zongming Zhang, Jiahong Dong, Fangcai Lin, Qiusheng Wang, Zhi Xu, Xiaodong He, Shizhong Yang, Youwei Li, Limin Liu, Chong Zhang, Zhuo Liu, Yue Zhao, Haiyan Yang, Shuyou Peng, Ting Gao, Xiuyuan Hao
Publikováno v:
Chinese Medical Journal, Vol 136, Iss 9, Pp 1037-1046 (2023)
Abstract. With the accelerated aging society in China, the incidence of biliary surgical diseases in the elderly has increased significantly. The clinical characteristics of these patients indicate that improving treatment outcomes and realizing heal
Externí odkaz:
https://doaj.org/article/419ea9dc1ad944418d4074b62a25d9d4
Autor:
Xiangsong Wu, Maolan Li, Wenguang Wu, Xu’an Wang, Huaifeng Li, Runfa Bao, Yijun Shu, Jun Shen, Jun Gu, Xuefeng Wang, Wei Gong, Shuyou Peng, Yingbin Liu, Yanjie Yin, Xiuyuan Hao
Publikováno v:
Chinese Medical Journal, Vol 135, Iss 23, Pp 2851-2858 (2022)
Abstract. Background:. Hepatopancreatoduodenectomy (HPD) has been considered the only curative treatment for metastatic cholangiocarcinoma and some locally advanced gallbladder cancers (GBCs). However, HPD has not yet been included in treatment guide
Externí odkaz:
https://doaj.org/article/8fe6387053bd423b8cd999ac45446680
Autor:
Zhiwei Wang, Yuanquan Yu, Peiyao Wu, Qinghuang Ye, Yinghao Guo, Xiaoxiao Zhang, Longfu Xi, Qi Li, Yun Jin, Donger Zhou, Yan Luo, Shuyou Peng, Jiangtao Li
Publikováno v:
Cell Death Discovery, Vol 8, Iss 1, Pp 1-10 (2022)
Abstract The long culture duration of patient-derived organoids (PDOs) have severely limited their clinical applications. The aim of this study was to determine the effect of lactate supplementation on the growth, genetic profiles and drug sensitivit
Externí odkaz:
https://doaj.org/article/6e32b570eaf244f28eab9376469375a5
Autor:
Zhiwei Wang, Yinghao Guo, Yun Jin, Xiaoxiao Zhang, Hao Geng, Guangyuan Xie, Dan Ye, Yuanquan Yu, Daren Liu, Donger Zhou, Baizhou Li, Yan Luo, Shuyou Peng, Jiangtao Li
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background Patient-derived organoids (PDO) have been proposed as a novel in vitro method of drug screening for different types of cancer. However, to date, extrahepatic biliary tract carcinoma (eBTC) PDOs have not yet been fully established.
Externí odkaz:
https://doaj.org/article/7bf40f1448b446f7b490989d29da0f7b
Autor:
Nan Xiao, Kailin Yu, Shaojun Yu, Jianjun Wu, Jian Wang, Siyang Shan, Shuchun Zheng, Liuhong Wang, Jianwei Wang, Shuyou Peng
Publikováno v:
World Journal of Surgical Oncology, Vol 15, Iss 1, Pp 1-5 (2017)
Abstract Background For colorectal liver metastasis (CRLM) patients, hepatic resection is currently the sole cure offering the chance of long-term survival. Tumor shrinkage and planned liver remnant hypertrophy are the two key strategies for conversi
Externí odkaz:
https://doaj.org/article/6c2623029ec24da7a08827849eba34fb
Autor:
Jiasheng Cao, Jiahao Hu, Jiliang Shen, Bin Zhang, Win Topatana, Shijie Li, Tianen Chen, Sarun Jeungpanich, Yitong Tian, Ziyi Lu, Shuyou Peng, Xiujun Cai, Mingyu Chen
Publikováno v:
iLIVER. 1:127-138
Autor:
Huanbing Zhu, Daren Liu, Donger Zhou, Jinhong Wu, Yuanquan Yu, Yun Jin, Dan Ye, Chao Ding, Xiaoxiao Zhang, Bingying Huang, Shuyou Peng, Jiangtao Li
Publikováno v:
Langenbeck's Archives of Surgery. 408
Autor:
Xiangsong Wu, Maolan Li, Wenguang Wu, Xu’an Wang, Huaifeng Li, Runfa Bao, Yijun Shu, Jun Shen, Jun Gu, Xuefeng Wang, Wei Gong, Shuyou Peng, Yingbin Liu
Publikováno v:
Chinese medical journal.
Hepatopancreatoduodenectomy (HPD) has been considered the only curative treatment for metastatic cholangiocarcinoma and some locally advanced gallbladder cancers (GBCs). However, HPD has not yet been included in treatment guidelines as a standard sur
Autor:
Zhiwei Wang, Yuanquan Yu, Peiyao Wu, Qinghuang Ye, Yinghao Guo, Xiaoxiao Zhang, Longfu Xi, Qi Li, Yun Jin, Donger Zhou, Yan Luo, Shuyou Peng, Jiang-Tao Li
Publikováno v:
SSRN Electronic Journal.